Publications by authors named "W C Kuijpers"
Article Synopsis
- The study aimed to analyze cocaine treatment demand across 10 Western European countries from 2011 to 2018, focusing on trends in the proportion of cocaine users among all treatment clients.
- Over 700,000 treatment records were reviewed, revealing that most clients (85%) were male with an average age of 35, and cocaine treatment demand varied significantly by country, peaking at 43.1% in Spain.
- The findings indicated a decline in cocaine-related treatment entrants from 2011 to 2014, followed by a notable increase in 2015, with significant rises in countries like Ireland, France, and England displaying annual percentage changes between 7.0% and
Aims: To compare long-term trends in wastewater data with other indicators of stimulant use in three locations and to test the reliability of estimates based on 1 week of sampling.
Design: Comparison of trends in quantities ('loads') of stimulants or their metabolites in wastewater with trends in other indicators of stimulant use (e.g.
Heroin users in opioid agonist treatment (OAT) show markedly reduced heroin consumption, less crime and a lower mortality rate. However, the extent of long-term OAT participation over subsequent treatment episodes remains unclear. We analysed the annual proportion of patients in treatment (at least 1 day) since the start of first OAT in 4 European regions: Barcelona (BA) 1996-2012: 8,602 patients; Czech -Republic (CZ) 2000-2014: 4,377 patients; Netherlands (NL) 1994-2014: 33,235 patients, Zurich (ZU) 1992-2015: 11,795.
View Article and Find Full Text PDFBackground: The number of people entering specialist drug treatment for cannabis problems has increased considerably in recent years. The reasons for this are unclear, but rising cannabis potency could be a contributing factor.
Methods: Cannabis potency data were obtained from an ongoing monitoring programme in the Netherlands.
Background: MyAVL is an interactive portal for cancer patients that aims to support lung cancer patients.
Objective: We aimed to evaluate the feasibility and usability of the patient portal and generate preliminary evidence on its impact.
Methods: Lung cancer patients currently or recently treated with curative intent could use MyAVL noncommittally for 4 months.